Samson, Emma Linda L.

HRN: 16-37-74  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2023
CEFTRIAXONE 1G (VIAL)
02/01/2023
02/07/2023
IV
2gm
Q24
UTI
Waiting Final Action 
02/02/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/02/2023
02/09/2023
IV
600mg
Q8
Cellulitis L Foot
Waiting Final Action 
02/10/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/10/2023
02/16/2023
IV
4.5g
Q8h
Cellulitis, R Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: